Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Ventral Hernia Treatment Market Forecast: What Market Value Is Expected By 2030?
The market for ventral hernia treatments has experienced robust expansion recently, projecting a rise from $5.22 billion in 2025 to $5.59 billion in 2026, fueled by a compound annual growth rate of 7.2%. This historical growth trend is largely attributable to the increased occurrence of abdominal hernias, a greater propensity for surgical interventions, the expanding use of laparoscopic surgical techniques, a wider availability of surgical mesh solutions, and enhanced utilization of diagnostic imaging technologies.
The market dedicated to the treatment of ventral hernias is poised for considerable expansion in the upcoming years, projecting a valuation of $7.3 billion by 2030, spurred by a compound annual growth rate of 6.9%. This anticipated growth over the forecast period is largely fueled by several key factors: a heightened embrace of robotic surgery systems, a mounting demand for repair methods that eliminate surgical tension, the proliferation of outpatient surgical facilities, a heightened emphasis on minimizing the recurrence of hernias, and escalating investments directed towards cutting-edge surgical innovations. Prominent trends shaping this market during the forecast period encompass the increasing integration of robotic assistance in hernia repairs, a greater utilization of sophisticated hernia mesh materials, a rising inclination towards less invasive surgical interventions, the expansion of same-day surgical care options, and refined protocols for recovery following surgery.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21315&type=smp
Ventral Hernia Treatment Market Development Factors: Which Trends Are Supporting Demand?
The escalating rates of obesity are anticipated to be a significant driver for the expansion of the ventral hernia treatment market. Obesity, recognized as a condition of excessive body fat accumulation with pronounced health implications, is increasingly attributable to factors such as unhealthy dietary habits, inactive lifestyles, genetic predispositions, insufficient physical activity, environmental pressures, and emotional distress. Ventral hernia treatments offer crucial support to individuals managing obesity by mitigating complications associated with excess weight; these treatments contribute to lessening pressure on the abdominal wall, diminishing the likelihood of hernia recurrence, and bolstering overall abdominal integrity, which are vital for improving mobility and fostering healthier lifestyle choices among those grappling with obesity. Significantly, in March 2024, the World Health Organization, an international body headquartered in Switzerland, highlighted that roughly one out of every eight individuals globally faces obesity, with 2.5 billion adults (18 years and older) being overweight, of whom 890 million are categorized as obese. Furthermore, within the adult population, 43% are overweight, and 16% fall into the obese category, while concurrently, the number of children under five years old who are overweight stands at 37 million, underscoring the substantial and growing population affected by obesity, thereby fueling the demand for ventral hernia treatments.
Ventral Hernia Treatment Market Categorization By Product Type And Application
The ventral hernia treatment market covered in this report is segmented –
1) By Type: Epigastric (Stomach Area) Hernia, Umbilical (Belly Button) Hernia, Incisional Hernia
2) By Diagnosis: Ultrasound, Computed Tomography (CT) Scan, Magnetic Resonance Imaging (MRI)
3) By Surgery: Open Hernia Surgery, Laparoscopic Surgery, Robotic Hernia Surgery
4) By End Users: Hospitals, Ambulatory Surgical Centres, Clinics
Subsegments:
1) By Epigastric (Stomach Area) Hernia: Small Epigastric Hernia, Large Epigastric Hernia
2) By Umbilical (Belly Button) Hernia: Congenital Umbilical Hernia, Acquired Umbilical Hernia
3) By Incisional Hernia: Primary Incisional Hernia, Recurrent Incisional Hernia
Ventral Hernia Treatment Market Transformation Trends: Which Innovations Are Driving Change?
Key players within the ventral hernia treatment sector are prioritizing innovations in surgical apparatus, specifically in mesh fixation technologies for both laparoscopic and open procedures. The objective behind these advancements is to elevate the success rates of surgeries, mitigate associated risks, and accelerate patient recuperation. Hernia mesh fixation devices, whether employed in laparoscopic (minimally invasive) or open surgery, are instrumental in stabilizing the mesh implant during the repair process. Illustrating this trend, TELA Bio Inc., a medical device firm based in the United States, introduced its LIQUIFIX FIX8 for laparoscopic use and LIQUIFIX precision for open hernia repairs in the U.S. market in March of 2024. The LIQUIFIX FIX8 is designed for minimally invasive procedures, while the LIQUIFIX precision targets open femoral and inguinal hernia repairs. These devices, having received FDA approval, employ a novel liquid anchoring system that secures the mesh without requiring penetration into bodily tissues, thereby minimizing trauma and potential complications. Considering that the U.S. witnesses more than 1.2 million hernia operations each year, the LIQUIFIX system is poised to offer enhanced accuracy and security, particularly in delicate anatomical regions, while simultaneously reducing the likelihood of damage to blood vessels or nerves.
Ventral Hernia Treatment Market Company Landscape And Strategic Competition
Major companies operating in the ventral hernia treatment market are Johnson & Johnson Services Inc., Medtronic Plc, Becton, Dickinson and Company (BD), Braun Melsungen AG, Olympus Corporation, W.L. Gore and Associates Inc, STERIS Plc, Cook Medical Inc, KARL STORZ, Cooper University Health Care, Mölnlycke Health Care, Integra LifeSciences Holdings, ConMed Corporation, Aesculap Inc, Richard Wolf GmbH, Ethicon Inc, Microline Surgical, Hernia Mesh S.R.L., Insightra Medical Inc, Advanced MedTech Solutions Pvt Ltd
Access The Complete Ventral Hernia Treatment Market Report:
https://www.thebusinessresearchcompany.com/report/ventral-hernia-treatment-global-market-report
Ventral Hernia Treatment Market Regional Analysis And Leading Geography
North Americawas the largest region in the ventral hernia treatment market in 2025. Europeis expected to be the fastest-growing region in the forecast period. The regions covered in the ventral hernia treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
